Cytokine gene polymorphisms in the susceptibility to acute coronary syndrome

Genetic Testing and Molecular Biomarkers

Volumn 16, Issue 5, 2012, Pages 359-365

  Srikanth Babu, Baddela M V ^a   Pulla Reddy, Bhomireddy ^a   Priya, Vanacherla Hari Sai ^b   Munshi, Anjana ^a   Surekha Rani, Hanmathrao ^a   Suman Latha, Gaddam ^b   Rao, V Dayasagar ^c   Jyothy, Akka ^a  

^a OSMANIA UNIVERSITY   (India)

^b Mahavir Charitable Hospital   (India)

^c Department of Cardiology   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; GAMMA INTERFERON; HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ACUTE CORONARY SYNDROME; ADULT; ALCOHOL CONSUMPTION; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DNA DETERMINATION; DNA POLYMORPHISM; FEMALE; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HEART LEFT VENTRICLE EJECTION FRACTION; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERTENSION; IMMUNOREGULATION; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SMOKING; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL;

ACUTE CORONARY SYNDROME; ADULT; CYTOKINES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INDIA; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-6; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84861490094     PISSN: 19450265     EISSN: 19450257     Source Type: Journal    
DOI: 10.1089/gtmb.2011.0182     Document Type: Article

References (49)

1. Antonicelli R, Olivieri F, Cavallone L, et al. (2005) Tumor necrosis factor alpha gene-308G >A polymorphism is associated with ST-elevation myocardial infarction and with high plasma levels of biochemical ischemia markers. Coron Artery Dis 16:489-493.
2. Barath P, Fishbein MC, Cao J, et al. (1990) Detection and localization of tumor necrosis factor in human atheroma. Am J Cardiol 65:297-302.
3. Basso F, Lowe GD, Rumley A, et al. (2002) Interleukin-6-174G >C polymorphism and the risk of coronary heart disease in West of Scotland coronary prevention study (WOSCOPS). Arterioscler Thromb Vasc Biol 22:599-604.
4. Belluco C, Olivieri F, Bonafe M, et al. (2003)-174G >C polymorphism of interleukin 6 gene promoter affects interleukin 6 serum level in patients with colorectal cancer. Clin Cancer Res 9:2173-2176.
5. Bidwell J, Keen L, Gallagher G, et al. (1999) Cytokine gene polymorphism in human disease: on-line database. Genes Immun 1:3-19.
6. Boiardi L, Casali B, Farnetti E, et al. (2006) Relationship between interleukin 6 promoter polymorphism at position 174, IL-6 serum levels, and the risk of relapse/recurrence in polymyalgia rheumatica. J Rheumatol 33:703-708.
7. Densem CG, Hutchinson IV, Yonan N, et al. (2002) Tumour necrosis factor a gene polymorphism: a predisposing factor to non-ischaemic myocardial dysfunction? Heart 87:153-155.
8. Fernandez-Real JM, Ricart W (2003) Insulin resistance and chronic cardiovascular inflammatory syndrome. Endocr. Rev 24:278-301.
9. Fishman D, Faulds G, Jeffery R, et al. (1998) The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemiconset juvenile chronic arthritis. J Clin Invest 102: 1369-1376.
10. Georges JL, Loukaci V, Poirier O, et al. (2001) Interleukin-6 gene polymorphisms and susceptibility to myocardial infarction. The ECTIM study. J Mol Med 79:303-305.
11. Giacconi R, Cipriano C, Albanese F, et al. (2004) The-174G/C polymorphism of IL-6 is useful to screen old subjects at risk for atherosclerosis or to reach successful ageing. Exp Gerontol 39:621-628.
12. Girndt M, Ulrich C, Kaul H, et al. (2003) Uremia-associated immune defect: the IL-10-CRP axis. Kidney Int 63:S76-S79.
13. Grzybowska EA, Wilczynska A, Siedlecki JA (2001) Regulatory functions of 3¢UTRs. Biochem Biophys Res Commun 288: 291-295.
14. Humphries SE, Luong LA, Ogg MS, et al. (2001) The interleukin-6-174 G/C promoter polymorphism is associated with risk of coronary heart disease and systolic blood pressure in healthy men. Eur Heart J 22:2243-2252.
15. Jenny NS, Tracy RP, Ogg MS, et al. (2002) In the elderly, interleukin-6 plasma levels and the-174G >C polymorphism are associated with the development of cardiovascular disease. Arterioscler Thromb Vasc Biol 22:2066-2071.
16. Jerrard-Dunne P, Sitzer M, Risley P, et al. (2003) Interleukin-6 promoter polymorphism modulates the effects of heavy alcohol consumption on early carotid artery atherosclerosis. Stroke 34:402-407.
17. Jones KG, Brull DJ, Brown LC, et al. (2001) Interleukin-6 (IL-6) and the prognosis of abdominal aortic aneurysms. Circulation 103:2260-2265.
18. Joshi P, Islam S, Pais P, et al. (2007) Risk factors for early myocardial infarction in South Asians compared with individuals in other countries. JAMA 297:286-294.
19. Karunakar VK, Madhavi G, Srikanth Babu BMV, et al. (2009) Association of tumor necrosis factor alpha, interferon gamma and interleukin10 gene polymorphisms with peripheral neuropathy in South Indian patients with type 2 diabetes. Cytokine 47:173-177.
20. Kroeger KM, Carville KS, Abraham LJ (1997) The-308 tumor necrosis factor alpha promoter polymorphism effects transcription. Mol Immunol 34:391-399.
21. Lahiri DK, Nurnberger JI (1991) A rapid non-enzymatic method for the preparation of HMW DNA from blood RFLP studies. Nucleic Acid Res 19: 5444.
22. Latsi P, Pantelidis P, Vassilakis D, et al. (2003) Analysis of IL-12 p40 subunit gene and IFN-g G5644A polymorphisms in idiopathic pulmonary fibrosis. Respir Res 4:6.
23. Lee TS, Yen HC, Pan CC, et al. (1999) The role of interleukin 12 in the development of atherosclerosis in ApoE-deficient mice. Arterioscler Thromb Vasc Biol 19:734-742.
24. Libby P, Ridker PM, Maseri A (2002) Inflammation and atherosclerosis. Circulation 105:1135-1143.
25. Lopez-Maderuelo D, Arnalich F, Serantes R, et al. (2004) Interferon-g and interleukin-10 gene polymorphisms in pulmonary tuberculosis. Am J Respir Crit Care Med 167:970-975.
26. Louis R, Leyder E, Malaise M, et al. (2000) Lack of association between adult asthma and the tumour necrosis factor a-308 polymorphism gene. Eur Respir J 16:604-608.
27. McLaren JE, Ramji DP (2009) Interferon gamma: a master regulator of atherosclerosis. Cytokine Growth Factor Rev 20: 125-135.
28. Momiyama Y, Ohmori R, Nagano M, et al. (2005) Polymorphism of the 3¢-untranslated region of interleukin-12 p40 gene is not associated with the presence or severity of coronary artery disease. Circ J 69:793-797.
29. Morahan G, Huang D, Wu M, et al. (2002) Association of IL12B promoter polymorphism with severity of atopic and non atopic asthma in children. Lancet 360:455-459.
30. Morse HR, Olomolaiye OO, Wood NA, et al. (1999) Induced heteroduplex genotyping of TNF-alpha, IL-1beta, IL-6 and IL-10 polymorphisms associated with transcriptional regulation. Cytokine 11:789-795.
31. Munshi A, Rajeshwar K, Kaul S, et al. (2010) Interleukin-10-1082 promoter polymorphism and ischemic stroke risk in a South Indian population. Cytokine 52:221-224.
32. Olomolaiye O, Wood NA, Bidwell JLA (1998) Novel Nla III polymorphism in the human IL-6 promoter. Eur J Immunogenet 25:267.
33. Perrey C, Turner SJ, Pravica V, et al. (1999) ARMS-PCR methodologies to determine IL-10, TNF-a, TNF-13 and TGF-131 gene polymorphism. Transpl Immunol 7:127-128.
34. Pravica V, Perrey C, Stevens A, et al. (2000) A single nucleotide polymorphism in the first intron of the human IFN-g gene: absolute correlation with a polymorphic CA microsatellite marker of high IFN-g production. Hum Immunol 61:863-866.
35. Rauramaa R, Vä isänen SB, Luong LA, et al. (2000) Stromeolysin-1 and interleukin-6 gene promoter polymorphisms are determinants of asymptomatic carotid artery atherosclerosis. Arterioscler Thromb Vasc Biol 20:2657-2662.
36. Reddy KS (2007) From around the world: focus on India. India wakes up to the threat of cardiovascular diseases. J Am Coll Cardiol 50:1370-1372.
37. Ridker PM, Hennekens CH, Buring JE, et al. (2000) C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 342:836-843.
38. Ross R (1999) Atherosclerosis-an inflammatory disease. N Engl J Med 340:115-126.
39. Seegers D, Zwiers A, Strober W, et al. (2002) A TaqI polymorphism in the 3'UTR of the IL-12 p40 gene correlates with increased IL-12 secretion. Genes Immun 3:419-423.
40. Sole X, Guino E, Valls J, et al. (2006) SNPStats: a web tool for the analysis of association studies. Bioinformatics 22: 1928-1929.
41. Tedgui A, Mallat Z (2001) Interleukin-10: an anti-atherogenic cytokine. Pathol Biol 49:107-108.
42. Trinchieri G, Pflanz S, Kastelein RA (2003) The IL-12 family of heterodimeric cytokines. New players in the regulation of T cell responses. Immunity 19: 641-644.
43. Turner DM, Williams DM, Sankaran D, et al. (1997) An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet 24:1-8.
44. Uyemura K, Demer LL, Castle SC, et al. (1996) Cross-regulatory roles of interleukin (IL)-12 and IL-10 in atherosclerosis. J Clin Invest 97:2130-2138.
45. Vaddi K, Nicolini FA, Mehta P, et al. (1994) Increased secretion of tumor necrosis factor-alpha and interferon-gamma by mononuclear leukocytes in patients with ischemic heart disease. Relevance in superoxide anion generation. Circulation 90:694-699.
46. Vickers MA, Green FR, Terry C, et al. (2002) Genotype at a promoter polymorphism of the interleukin-6 gene is associated with baseline levels of plasma C-reactive protein. Cardiovasc Res 53:1029-1034.
47. Weger M, Steinbrugger I, Haas A, et al. (2005) Role of the interleukin-6-174 G>C gene polymorphism in retinal artery occlusion. Stroke 36:249-252.
48. Wilson AG, Symons JA, McDowell TL, et al. (1997) Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci USA 94:3195-3199.
49. Yoo JH, Seo BH, Kim YS (2005) SNPAnalyzer: a web-based integrated workbench for single-nucleotide polymorphism analysis. Nucleic Acids Res 33:483-488.